{"id":448693,"title":"Guidance for Sponsors: Lot Release Program for Schedule D (Biologic) Drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T17:34:20.246000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/release/guidance-sponsors-program-schedule-biologic-drugs.html?wbdisable=false","snippet":"Guidance for Sponsors: Lot Release Program for Schedule D (Biologic) Drugs (PDF Version - 138 K) Contact: Regulatory Affairs Division Date: 2005-06-01 Table of Contents 1.0 Introduction 1.1 Purpose 1.2 The Lot Release Program 1.3 Scope 1.4 Abbreviations, Acronyms, and Definitions…","rawSnapshotUrl":"/api/snapshots/raw/448693","browseUrl":"https://replay.healtharchive.ca/job-6/20260103173420/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/release/guidance-sponsors-program-schedule-biologic-drugs.html?wbdisable=false#ha_snapshot=448693","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}